Alzheimer's & Dementia·26 SepClinical utility of LUMIPULSE plasma p-tau217 to identify amyloid positivity among candidates for amyloid-targeting treatments in a real-world cohortCohort study of 99 peoplep-Tau217Paper
AAIC 2025 Abstract·9 Jan[ ¹⁸ F]SMBT‐1 PET as an Imaging Biomarker for Reactive Astrogliosis in Mild Cognitive Impairment and Alzheimer's DiseaseStudy in peopleBiomarkersPaper
AAIC 2025 Abstract·24 DecComparison of renal effect on various plasma tau assays in reference to CSF valuesStudy in peopleBiomarkersPaper
AAIC 2025 Abstract·23 Dec[ ¹⁸ F]SMBT‐1 PET as an Imaging Biomarker for Reactive Astrogliosis in Mild Cognitive Impairment and Alzheimer's DiseaseStudy in peopleBiomarkersPaper